Produktbild: Heart Failure

Heart Failure Frontiers in Cardiology

Fr. 73.90

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

24.02.2012

Herausgeber

A. Kitabatake + weitere

Verlag

Springer Tokyo

Seitenzahl

261

Maße (L/B/H)

23.5/15.5/1.6 cm

Gewicht

423 g

Auflage

Softcover reprint of the original 1st ed. 2000

Sprache

Englisch

ISBN

978-4-431-68333-9

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

24.02.2012

Herausgeber

Verlag

Springer Tokyo

Seitenzahl

261

Maße (L/B/H)

23.5/15.5/1.6 cm

Gewicht

423 g

Auflage

Softcover reprint of the original 1st ed. 2000

Sprache

Englisch

ISBN

978-4-431-68333-9

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Heart Failure
  • 1 New Insights in the Pathophysiology of Heart Failure.- 1.1 Neurohormones in Advanced Heart Failure.- 1.2 Recent Progress in Natriuretic Hormone Research.- 1.3 Cytokines and Heart Failure: Pathophysiological Roles and Therapeutic Implications.- 1.4 Endothelium Dysfunction in Heart Failure: A Review.- 1.5 Pathogenesis of Myocardial Injury and Cell Death in Myocarditis: Its Relation to the Fas/Fas Ligand Pathway.- 1.6 Mechanisms of Acute Cardioprotection with Ischemic Preconditioning: Protein Kinase C and Beyond.- 1.7 Role of NO in Myocardial Injury Induced by Oxidative Stress: Ischemia, Myocarditis, Cardiomyopathy, and Heart Failure.- 1.8 Cardiac Remodeling: Role of Neovascularization in Heart Failure.- 2 Heart Failure and Cardiac Sudden Death.- 2.1 Long QT Syndrome as a Cause of Cardiac Sudden Death.- 2.2 ICD Therapy: Can It Prevent Sudden Death in CHF Patients?.- 2.3 Antiarrhythmic Drug Therapy for Sudden Cardiac Death in CHF Guided by the Sicilian Gambit.- 3 Medical Treatment of Heart Failure: Beyond ACE Inhibitors.- 3.1 Clinical Practice Guidelines in Heart Failure: State of the Art in the United States.- 3.2 Beyond ACE Inhibitors: Angiotensin II Antagonism in Heart Failure, An Emerging Role for Losartan.- 3.3 Beta-blockers in Heart Failure: Where Do We Stand Today?.- 3.4 Endothelin Antagonism in the Treatment of Heart Failure.- 3.5 Heart Failure: Potential Benefit of Growth Hormone Therapy.- 3.6 Role of Adenosine in Cardioprotection.- 4 Gene Therapy for Heart Failure: Current Status and Future Prospects.- 4.1 In Vivo Gene Supplementation for the Therapy of Cardiomyopathy.- 4.2 ?-Adrenergic Receptor Desensitization in Cardiac Disease: Insights from Gene-Targeted Mice.- 4.3 Gene Therapy for Myocardial Infarction: A Real Medicine in the Next Millenium?.- 4.4 FromScar Tissues to Viable Myocytes: A Novel Therapeutic Strategy for the Treatment of Heart Failure.- 5 Surgical Treatment for Heart Failure.- 5.1 Treatment of Profound Heart Failure by Ventricular Assist System.- 5.2 Left Ventriculoplasty for End-Stage Cardiomyopathy.